Infectious Disease Therapy
Novel munumbicin antibiotics show broad-spectrum activity
Published in TB and Outbreaks Week, November 26th, 2002
"Munumbicins A, B, C and D are newly described antibiotics with a wide spectrum of activity against many human as well as plant pathogenic fungi and bacteria, and a Plasmodium sp.," explained Uvidelio F. Castillo and colleagues working at Montana State University in Bozeman, Brigham Young University in Provo, Utah, Harvard Medical School in Boston, the University of Washington in Seattle, and Veterans Affairs Medical Center in Boise, Idaho. "These compounds were obtained from Streptomyces NRRL 3052,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Tuberculosis Pathogenesis
Toll-like receptor 4 needed for efficient immune control - Infectious Disease Therapy
Novel compound highly effective against cytomegalovirus infection - Infectious Disease Therapy
Superantigens can enhance antimicrobial, anti-HIV immune activity - Infectious Disease Vaccine
Vaccine protects against aspergillosis - Tuberculosis Pathogenesis
Bcl-2 upregulation underlies mycobacterial persistence - Antibiotic Resistance
New type of antiobiotic tackles hard-to-treat pediatric infections - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
